ProQR Therapeutics N.V. Interest Expense
ProQR Therapeutics N.V. (PRQR) reported Interest Expense of EUR 929.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpense · last filed 2026-03-12
| Period end | Interest Expense 12 month |
|---|---|
| 2025-12-31 | 929.00K EUR 20-F · filed 2026-03-12 |
| 2024-12-31 | 1.08M EUR 20-F · filed 2026-03-12 |
| 2023-12-31 | 1.20M EUR 20-F · filed 2026-03-12 |
| 2021-12-31 | 3.40M EUR 20-F · filed 2022-04-29 |
| 2020-12-31 | 2.04M EUR 20-F · filed 2023-03-29 |